Modified Restriction Enzyme-based Detection of EGFR Mutations in Lung Cancer

Background and objective Epidermal growth factor receptor (EGFR) gene mutation in lung cancer is a reliable predictor of the efficacy of tyrosine kinase inhibitors, so detection of gene mutation has very important clinical significance. The aim of this study is to optimize conditions for restriction...

Full description

Bibliographic Details
Main Authors: Fan YANG, Kezhong CHEN, Guanchao JIANG, Jianfeng LI, Jun WANG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2011-08-01
Series:Chinese Journal of Lung Cancer
Subjects:
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2011.08.01
_version_ 1818989226008510464
author Fan YANG
Kezhong CHEN
Guanchao JIANG
Jianfeng LI
Jun WANG
author_facet Fan YANG
Kezhong CHEN
Guanchao JIANG
Jianfeng LI
Jun WANG
author_sort Fan YANG
collection DOAJ
description Background and objective Epidermal growth factor receptor (EGFR) gene mutation in lung cancer is a reliable predictor of the efficacy of tyrosine kinase inhibitors, so detection of gene mutation has very important clinical significance. The aim of this study is to optimize conditions for restriction enzyme-based mutant enriched detection of EGFR mutation in lung cancer specimens. Methods EGFR somatic mutations identified in DNA specimens from 251 lung adenocarcinomas with modified mutant enriched method and direct sequencing were compared. The sensitivity of the modified method was determined by serial dilution of mutant-carrying lung cancer cells in wild-type cells. Results 46 deletion mutations in exon 19 and 26 point mutations in exon 21 were found by sequencing, while modified method identified another 78 deletions in exon 19 and 57 substitutions in exon 21 with a mutation rate of 53.8%. Sensitivity of this modified method was 0.5% (mutant/wild type) in serial diluted cells. Conclusion The modified restriction enzyme-based method is convenient for clinical EGFR mutation screening in non-small cell lung cancer for its simpleness, cost-saving and high sensitivity.
first_indexed 2024-12-20T19:35:06Z
format Article
id doaj.art-59f29bb5f9504883aa8283134724c77c
institution Directory Open Access Journal
issn 1009-3419
1999-6187
language zho
last_indexed 2024-12-20T19:35:06Z
publishDate 2011-08-01
publisher Chinese Anti-Cancer Association; Chinese Antituberculosis Association
record_format Article
series Chinese Journal of Lung Cancer
spelling doaj.art-59f29bb5f9504883aa8283134724c77c2022-12-21T19:28:41ZzhoChinese Anti-Cancer Association; Chinese Antituberculosis AssociationChinese Journal of Lung Cancer1009-34191999-61872011-08-0114863764110.3779/j.issn.1009-3419.2011.08.01Modified Restriction Enzyme-based Detection of EGFR Mutations in Lung CancerFan YANGKezhong CHENGuanchao JIANGJianfeng LIJun WANGBackground and objective Epidermal growth factor receptor (EGFR) gene mutation in lung cancer is a reliable predictor of the efficacy of tyrosine kinase inhibitors, so detection of gene mutation has very important clinical significance. The aim of this study is to optimize conditions for restriction enzyme-based mutant enriched detection of EGFR mutation in lung cancer specimens. Methods EGFR somatic mutations identified in DNA specimens from 251 lung adenocarcinomas with modified mutant enriched method and direct sequencing were compared. The sensitivity of the modified method was determined by serial dilution of mutant-carrying lung cancer cells in wild-type cells. Results 46 deletion mutations in exon 19 and 26 point mutations in exon 21 were found by sequencing, while modified method identified another 78 deletions in exon 19 and 57 substitutions in exon 21 with a mutation rate of 53.8%. Sensitivity of this modified method was 0.5% (mutant/wild type) in serial diluted cells. Conclusion The modified restriction enzyme-based method is convenient for clinical EGFR mutation screening in non-small cell lung cancer for its simpleness, cost-saving and high sensitivity.http://dx.doi.org/10.3779/j.issn.1009-3419.2011.08.01Lung neoplasmsEpidermal growth factor receptorMutation
spellingShingle Fan YANG
Kezhong CHEN
Guanchao JIANG
Jianfeng LI
Jun WANG
Modified Restriction Enzyme-based Detection of EGFR Mutations in Lung Cancer
Chinese Journal of Lung Cancer
Lung neoplasms
Epidermal growth factor receptor
Mutation
title Modified Restriction Enzyme-based Detection of EGFR Mutations in Lung Cancer
title_full Modified Restriction Enzyme-based Detection of EGFR Mutations in Lung Cancer
title_fullStr Modified Restriction Enzyme-based Detection of EGFR Mutations in Lung Cancer
title_full_unstemmed Modified Restriction Enzyme-based Detection of EGFR Mutations in Lung Cancer
title_short Modified Restriction Enzyme-based Detection of EGFR Mutations in Lung Cancer
title_sort modified restriction enzyme based detection of egfr mutations in lung cancer
topic Lung neoplasms
Epidermal growth factor receptor
Mutation
url http://dx.doi.org/10.3779/j.issn.1009-3419.2011.08.01
work_keys_str_mv AT fanyang modifiedrestrictionenzymebaseddetectionofegfrmutationsinlungcancer
AT kezhongchen modifiedrestrictionenzymebaseddetectionofegfrmutationsinlungcancer
AT guanchaojiang modifiedrestrictionenzymebaseddetectionofegfrmutationsinlungcancer
AT jianfengli modifiedrestrictionenzymebaseddetectionofegfrmutationsinlungcancer
AT junwang modifiedrestrictionenzymebaseddetectionofegfrmutationsinlungcancer